vs
Side-by-side financial comparison of Orange County Bancorp, Inc. (OBT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $33.0M, roughly 1.7× Orange County Bancorp, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -83.0%, a 120.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 20.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 14.3%).
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
OBT vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $33.0M | $57.3M |
| Net Profit | $12.4M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 41.4% | -82.2% |
| Net Margin | 37.6% | -83.0% |
| Revenue YoY | 20.6% | 36.9% |
| Net Profit YoY | 73.5% | -9.6% |
| EPS (diluted) | $0.94 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $33.0M | $57.3M | ||
| Q3 25 | $33.7M | $51.3M | ||
| Q2 25 | $32.5M | $48.5M | ||
| Q1 25 | $28.0M | $32.7M | ||
| Q4 24 | $27.4M | $41.8M | ||
| Q3 24 | $27.1M | $33.3M | ||
| Q2 24 | $27.9M | $29.1M | ||
| Q1 24 | $25.3M | $26.0M |
| Q4 25 | $12.4M | $-47.5M | ||
| Q3 25 | $10.0M | $-52.9M | ||
| Q2 25 | $10.5M | $-46.6M | ||
| Q1 25 | $8.7M | $-49.5M | ||
| Q4 24 | $7.2M | $-43.3M | ||
| Q3 24 | $3.2M | $-43.6M | ||
| Q2 24 | $8.2M | $-32.3M | ||
| Q1 24 | $9.3M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 41.4% | -82.2% | ||
| Q3 25 | 38.6% | -102.6% | ||
| Q2 25 | 41.9% | -93.4% | ||
| Q1 25 | 40.3% | -143.7% | ||
| Q4 24 | 32.8% | -98.6% | ||
| Q3 24 | 14.8% | -132.0% | ||
| Q2 24 | 36.6% | -139.2% | ||
| Q1 24 | 45.9% | -538.7% |
| Q4 25 | 37.6% | -83.0% | ||
| Q3 25 | 29.7% | -103.1% | ||
| Q2 25 | 32.2% | -96.1% | ||
| Q1 25 | 31.1% | -151.4% | ||
| Q4 24 | 26.2% | -103.6% | ||
| Q3 24 | 11.8% | -131.2% | ||
| Q2 24 | 29.4% | -110.9% | ||
| Q1 24 | 36.7% | -544.4% |
| Q4 25 | $0.94 | $-0.73 | ||
| Q3 25 | $0.75 | $-0.82 | ||
| Q2 25 | $0.87 | $-0.75 | ||
| Q1 25 | $0.77 | $-0.81 | ||
| Q4 24 | $0.64 | $-0.71 | ||
| Q3 24 | $0.28 | $-0.73 | ||
| Q2 24 | $0.73 | $-0.55 | ||
| Q1 24 | $0.82 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $284.4M | $139.1M |
| Total Assets | $2.7B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $284.4M | $139.1M | ||
| Q3 25 | $270.1M | $148.8M | ||
| Q2 25 | $252.6M | $-11.9M | ||
| Q1 25 | $201.3M | $18.9M | ||
| Q4 24 | $185.5M | $21.7M | ||
| Q3 24 | $193.1M | $11.2M | ||
| Q2 24 | $177.5M | $39.3M | ||
| Q1 24 | $168.7M | $61.6M |
| Q4 25 | $2.7B | $480.2M | ||
| Q3 25 | $2.6B | $506.9M | ||
| Q2 25 | $2.6B | $372.7M | ||
| Q1 25 | $2.6B | $386.7M | ||
| Q4 24 | $2.5B | $392.3M | ||
| Q3 24 | $2.5B | $363.6M | ||
| Q2 24 | $2.5B | $381.8M | ||
| Q1 24 | $2.5B | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.8M | $-25.4M |
| Free Cash FlowOCF − Capex | $41.3M | — |
| FCF MarginFCF / Revenue | 125.1% | — |
| Capex IntensityCapex / Revenue | 7.6% | — |
| Cash ConversionOCF / Net Profit | 3.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $69.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.8M | $-25.4M | ||
| Q3 25 | $30.2M | $-26.6M | ||
| Q2 25 | $-5.0M | $-23.3M | ||
| Q1 25 | $4.8M | $-40.4M | ||
| Q4 24 | $34.6M | $-18.8M | ||
| Q3 24 | $10.2M | $-25.2M | ||
| Q2 24 | $9.3M | $-29.1M | ||
| Q1 24 | $2.3M | $-40.7M |
| Q4 25 | $41.3M | — | ||
| Q3 25 | $29.6M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $4.3M | — | ||
| Q4 24 | $32.9M | — | ||
| Q3 24 | $10.0M | — | ||
| Q2 24 | $9.2M | — | ||
| Q1 24 | $2.0M | — |
| Q4 25 | 125.1% | — | ||
| Q3 25 | 87.8% | — | ||
| Q2 25 | -17.5% | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 120.0% | — | ||
| Q3 24 | 36.7% | — | ||
| Q2 24 | 32.8% | — | ||
| Q1 24 | 7.9% | — |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 3.53× | — | ||
| Q3 25 | 3.01× | — | ||
| Q2 25 | -0.47× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 4.83× | — | ||
| Q3 24 | 3.19× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
